Insomnia after cerebral infarction with cognitive dysfunction
Conditions
Interventions
Acupuncture group:Filiform needle acupuncture
Electroacupuncture group:Electroacupuncture
Electroacupuncture control group :Electroacupuncture
Sham acupuncture group:Filiform needle acupuncture
Drug control group :Estazolam Tablets
Blank group :None
Sponsors
The Second Affiliated Hospital of Heilongjiang University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
40 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) Meet the diagnostic criteria for insomnia after cerebral infarction with cognitive dysfunction; (2) Between 40-65 years old.The course of disease was 3 months ~2 years; (3) Lesions located in the basal ganglia of the non dominant hemisphere, stable condition, completing the assessment of scales independently; (4) Keeping seated, PSG overnight test and MRI scan can be accepted; (5) There were no sleep disorders, cognitive impairment, or transient sleep disturbances before the onset of the disease; (6) Recently (within 1 weeks), there was no treatment related to the trial; (7) Voluntarily participate and sign informed consent.;Inclusion criteria: (1) Meet the diagnostic criteria for insomnia after cerebral infarction with cognitive dysfunction; (2) Between 40-65 years old.The course of disease was 3 months ~2 years; (3) Lesions located in the basal ganglia of the non dominant hemisphere, stable condition, completing the assessment of scales independently; (4) Keeping seated, PSG overnight test and MRI scan can be accepted; (5) There were no sleep disorders, cognitive impairment, or transient sleep disturbances before the onset of the disease; (6) Recently (within 1 weeks), there was no treatment related to the trial; (7) Voluntarily participate and sign informed consent.;Inclusion criteria: (1) Meet the diagnostic criteria for insomnia after cerebral infarction with cognitive dysfunction; (2) Between 40-65 years old.The course of disease was 3 months ~2 years; (3) Lesions located in the basal ganglia of the non dominant hemisphere, stable condition, completing the assessment of scales independently; (4) Keeping seated, PSG overnight test and MRI scan can be accepted; (5) There were no sleep disorders, cognitive impairment, or transient sleep disturbances before the onset of the disease; (6) Recently (within 1 weeks), there was no treatment related to the trial; (7) Voluntarily participate and sign informed consent.;Inclusion criteria: (1) Meet the diagnostic criteria for insomnia after cerebral infarction with cognitive dysfunction; (2) Between 40-65 years old.The course of disease was 3 months ~2 years; (3) Lesions located in the basal ganglia of the non dominant hemisphere, stable condition, completing the assessment of scales independently; (4) Keeping seated, PSG overnight test and MRI scan can be accepted; (5) There were no sleep disorders, cognitive impairment, or transient sleep disturbances before the onset of the disease; (6) Recently (within 1 weeks), there was no treatment related to the trial; (7) Voluntarily participate and sign informed consent.;Inclusion criteria: (1) Meet the diagnostic criteria for insomnia after cerebral infarction with cognitive dysfunction; (2) Between 40-65 years old.The course of disease was 3 months ~2 years; (3) Lesions located in the basal ganglia of the non dominant hemisphere, stable condition, completing the assessment of scales independently; (4) Keeping seated, PSG overnight test and MRI scan can be accepted; (5) There were no sleep disorders, cognitive impairment, or transient sleep disturbances before the onset of the disease; (6) Recently (within 1 weeks), there was no treatment related to the trial; (7) Voluntarily participate and sign informed consent.
Exclusion criteria
Exclusion criteria: (1) Failure to meet diagnostic criteria; (2) Less than 40 years old, or more than 65 years old; (3) The course of disease was less than 3 months, or more than 2 years; (4) Patients with consciousness disorder or severe illness after cerebral infarction can not cooperate with related examinations; (5) Severe mental disorders or patients with previous history of mental illness; (6) Combined with severe cardiopulmonary failure or other serious somatic diseases; (7) Before the onset of cerebral infarction, the patient has been diagnosed with sleep disorders or cognitive impairment; (8) There are metal residues in the body, deep vein catheterization can not be scanned or affect the image quality; (9) Patients who took drugs for the central nervous system( diazepam, antidepressants, antipsychotics) in the last 1 months.;Exclusion criteria: (1) Failure to meet diagnostic criteria; (2) Less than 40 years old, or more than 65 years old; (3) The course of disease was less than 3 months, or more than 2 years; (4) Patients with consciousness disorder or severe illness after cerebral infarction can not cooperate with related examinations; (5) Severe mental disorders or patients with previous history of mental illness; (6) Combined with severe cardiopulmonary failure or other serious somatic diseases; (7) Before the onset of cerebral infarction, the patient has been diagnosed with sleep disorders or cognitive impairment; (8) There are metal residues in the body, deep vein catheterization can not be scanned or affect the image quality; (9) Patients who took drugs for the central nervous system( diazepam, antidepressants, antipsychotics) in the last 1 months.;Exclusion criteria: (1) Failure to meet diagnostic criteria; (2) Less than 40 years old, or more than 65 years old; (3) The course of disease was less than 3 months, or more than 2 years; (4) Patients with consciousness disorder or severe illness after cerebral infarction can not cooperate with related examinations; (5) Severe mental disorders or patients with previous history of mental illness; (6) Combined with severe cardiopulmonary failure or other serious somatic diseases; (7) Before the onset of cerebral infarction, the patient has been diagnosed with sleep disorders or cognitive impairment; (8) There are metal residues in the body, deep vein catheterization can not be scanned or affect the image quality; (9) Patients who took drugs for the central nervous system( diazepam, antidepressants, antipsychotics) in the last 1 months.;Exclusion criteria: (1) Failure to meet diagnostic criteria; (2) Less than 40 years old, or more than 65 years old; (3) The course of disease was less than 3 months, or more than 2 years; (4) Patients with consciousness disorder or severe illness after cerebral infarction can not cooperate with related examinations; (5) Severe mental disorders or patients with previous history of mental illness; (6) Combined with severe cardiopulmonary failure or other serious somatic diseases; (7) Before the onset of cerebral infarction, the patient has been diagnosed with sleep disorders or cognitive impairment; (8) There are metal residues in the body, deep vein catheterization can not be scanned or affect the image quality; (9) Patients who took drugs for the central nervous system( diazepam, antidepressants, antipsychotics) in the last 1 months.;Exclusion criteria: (1) Failure to meet diagnostic criteria; (2) Less than 40 years old, or more than 65 years old; (3) The course of disease was less than 3 months, or more than 2 years; (4) Patients with consciousness disorder or severe illness after cerebral infarction can not cooperate with related examinations; (5) Severe mental disorders or patients with previous history of mental illness; (6) Combined with severe cardiopulmonary failure or other serious somatic diseases; (7) Before the onset of cerebral infarction, the patient has been diagnosed with sleep disorders or cognitive impairment; (8) There are metal residues in the body, deep vein catheterization can not be scanned or affect the image quality; (9) Patients who took drugs for the central nervous system( diazepam, antidepressants, antipsychotics) in the last 1 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Polysomnography;Functional magnetic resonance imaging;Electroencephalogram;Psychomotor vigilance task;Karolinska Drowsiness Test; | — |
Secondary
| Measure | Time frame |
|---|---|
| Karolinska Sleepiness Scale;Short term memory experiment;Mini-Mental State Examination;Montreal Cognitive Assessment;Sleep diary;Actigraphy;Epworth Sleepiness Scale; | — |
Countries
China
Contacts
Public ContactDongyan Wang;Dongyan Wang;Dongyan Wang;Dongyan Wang;Dongyan Wang ;;;;
Heilongjiang University Of Chinese Medicine;Heilongjiang University Of Chinese Medicine;Heilongjiang University Of Chinese Medicine;Heilongjiang University Of Chinese Medicine;Heilongjiang University Of Chinese Medicine
Outcome results
None listed